IgA nephropathy: molecular mechanisms of the disease.
@article{Mestecky2013IgANM, title={IgA nephropathy: molecular mechanisms of the disease.}, author={Jiri F. Mestecky and Milan Ra{\vs}ka and Bruce A Julian and Ali G. Gharavi and Matthew B. Renfrow and Zina Moldoveanu and Lea Novak and Karel Matou{\vs}ovic and Jan Novak}, journal={Annual review of pathology}, year={2013}, volume={8}, pages={ 217-40 } }
Studies of molecular and cellular interactions involved in the pathogenesis of IgA nephropathy have revealed the autoimmune nature of this most common primary glomerulonephritis. In patients with this disease, altered glycan structures in the unique hinge region of the heavy chains of IgA1 molecules lead to the exposure of antigenic determinants, which are recognized by naturally occurring antiglycan antibodies of the IgG and/or IgA1 isotype. As a result, nephritogenic immune complexes form in…
Figures and Tables from this paper
54 Citations
The genetics and immunobiology of IgA nephropathy.
- Biology, MedicineThe Journal of clinical investigation
- 2014
New insights are summarized into the role of the O-glycosylation pathway, anti-glycan immune response, mucosal immunity, antigen processing and presentation, and the alternative complement pathway in the pathogenesis of IgAN.
Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.
- Biology, MedicineSeminars in nephrology
- 2018
IgA glycosylation and immune complex formation in IgAN
- Biology, MedicineSeminars in Immunopathology
- 2021
Complement activation through alternative and/or lectin pathways is likely playing an important role in the pathogenic properties of these complexes and may further upregulate local inflammatory responses and glomerular injury.
A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy.
- Biology, MedicineKidney international
- 2019
History of IgA Nephropathy Mouse Models
- Biology, MedicineJournal of clinical medicine
- 2021
All murine IgAN models developed since 1968 are reviewed and their remarkable contribution to understanding the disease is discussed.
Multi-hit Pathogenesis of IgA Nephropathy
- Medicine, BiologyJuntendo Medical Journal
- 2019
A highly sensitive and specific diagnostic method is developed by measuring serum levels of Gd-IgA1 and GD-IGA1 contained immune complexes, which confirmed a significant correlation between serum Levels of these effector molecules and disease activity, suggesting that each can be considered as a practical surrogate marker of therapeutic response.
IL-6 and its role in IgA nephropathy development.
- Biology, MedicineCytokine & growth factor reviews
- 2022
Is There a Role for Gut Microbiome Dysbiosis in IgA Nephropathy?
- Biology, MedicineMicroorganisms
- 2022
Fecal microbiota transplantation experiments in mice using stools from patients reveal a possible microbiota dysbiosis in IgAN with the capacity to induce progression of the disease whereas FMT from healthy hosts has beneficial effects in mice.
References
SHOWING 1-10 OF 150 REFERENCES
Progress in Molecular and Genetic Studies of IgA Nephropathy
- Biology, MedicineJournal of Clinical Immunology
- 2004
Recent progress in molecular analyses of IgA nephropathy defines this disease as an autoimmune process with a novel IgA mesangial receptor and certain genetically determined traits.
The pathophysiology of IgA nephropathy.
- Biology, MedicineJournal of the American Society of Nephrology : JASN
- 2011
Recent advances in understanding the biochemical, immunologic, and genetic pathogenesis of IgA nephropathy are discussed, and five distinct susceptibility loci are identified that potentially influence these processes and contain candidate mediators of disease.
The pathogenesis of IgA nephropathy
- Biology, MedicineCurrent opinion in nephrology and hypertension
- 2011
Progress in understanding the details of the pathogenesis of IgA nephropathy will lead to a better means of diagnosis, more accurate individualized prognosis and personalized treatment regimens for this globally distributed and very common primary glomerular disease.
The genetics of IgA nephropathy
- Medicine, BiologyNature Clinical Practice Nephrology
- 2007
The evidence for genetic contributions to the disease, clinical patterns of familial disease, and some of the most promising genetic studies conducted to date are presented.
Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
- Medicine, BiologyAdvances in oto-rhino-laryngology
- 2011
IgA nephropathy is an auto-immune disease, induced by mesangial deposition of circulating complexes containing galactose-deficient IgA1, and the aberrant glycosylation of IgA 1 may reflect abnormal mucosal immune responses to infections of the upper respiratory tract in genetically predisposed individuals.
Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus.
- Biology, MedicineThe Journal of clinical investigation
- 1980
To further characterize the IgA deposits found in glomeruli of patients with IgA nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus, renal biopsies from patients with…
Recent advances in IgA nephropathy--the glomerulopodocytic-tubular communication.
- Medicine, BiologyAdvances in oto-rhino-laryngology
- 2011
In vitro study implicates humoral factors released from mesangial cells alter the glomerular permeability in the event of proteinuria and tubulointerstitial injury in IgAN, leading to subsequent inflammatory changes in the renal tubulointerstitium.
The glomerular response to IgA deposition in IgA nephropathy.
- Biology, MedicineSeminars in nephrology
- 2008
IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.
- Medicine, BiologyKidney international
- 2005
It is suggested that CIC containing aberrantly glycosylated IgA1 affect proliferation of MC in vitro and, thus, likely play a role in the pathogenesis of IgAN.